Camber launches generic Zetia
PISCATAWAY, N.J. — Camber Pharmaceuticals nnounces the addition of ezetimibe tablets, USP to its current portfolio. Ezetimibe tablets, USP are an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet to: Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA
